Review Article
Perioperative Anesthesiological Management of Patients with Pulmonary Hypertension
Table 4
Therapy of pulmonary hypertension: approved drugs (mod. [
8]).
| Drug | | Dosage | Side effect |
| Bosentan | Endothelin receptor antagonist | 2 × 62,5–125 mg/d po | Increase of liver enzymes edema | Ambrisentan | Selective endothelin-A Receptor-antagonist | 1 × 5–10 mg/d po | Increase of liver enzymes edema | Sildenafil | PDE-5 inhibitor | 3 × 20 mg/d po | Reflux esophagitis | Tadalafil | PDE-5 inhibitor | 1 × 40 mg/d po | Headache and pain in the limbs | Iloprost | Prostacyclin-analog | 6–9 × 2,5/5 μg inhalative | Hypotension and flush | Treprostinil | Prostacyclin-analog | 1,25–22,5 ng/kg/min s.c. | Local pain |
|
|